Powered by

Israeli biotech companies come to U.S. for financing

Dec 03, 2015 - The Deal Pipeline

A growing number of Israeli biotech companies are raising money in the U.S. capital markets and opting for dual listings on Nasdaq and the Tel Aviv Stock Exchange.

The increase in private-investment-in-public-equity deals tied to U.S.-registered, Israel-based companies comes at the same time that initial public offerings by Israeli companies have jumped. Since January 2014, 14 Israeli companies have gone public in the U.S.--nine of those were life science companies--raising $423.3 million,...